← Back to headlines
AbbVie Reports Successful Late-Stage Trial for Multiple Myeloma Treatment
The pharmaceutical company announced positive results from its final clinical testing phase for a new therapy targeting multiple myeloma, advancing potential options for blood cancer patients.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
